Apimeds Pharmaceuticals US, Inc. (APUS) Form 10-Q Quarterly Reports
Apimeds Pharmaceuticals US, Inc. (APUS) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: APUS
CIK: 1894525
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kreit & Chiu CPA LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerSteven Kreit
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-01 | 2026-09-29 | CURRENT REPORT | 0001213900-26-105484 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-24 | CURRENT REPORT | 0001213900-26-104668 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-07-24 | CURRENT REPORT | 0001213900-26-102321 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-10 | CURRENT REPORT | 0001213900-26-099002 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-19 | CURRENT REPORT | 0001213900-26-092680 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-090120 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-05 | CURRENT REPORT | 0001213900-26-086244 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-13 | CURRENT REPORT | 0001213900-26-077591 | View SEC Doc Filr Page |
| 10-Q | 2026-05-26 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-061013 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-15 | 2026-03-31 | NOTIFICATION OF LATE FILING | 0001213900-26-057713 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-07 | — | SCHEDULE 13D/A Filing | 0001213900-26-053091 | View SEC Doc Filr Page |
| 8-K | 2026-05-05 | 2026-05-05 | CURRENT REPORT | 0001213900-26-052036 | View SEC Doc Filr Page |
| 10-K | 2026-05-04 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-051139 | View SEC Doc Filr Page |
| 8-K | 2026-05-04 | 2026-04-24 | CURRENT REPORT | 0001213900-26-051125 | View SEC Doc Filr Page |
| 8-K | 2026-04-22 | 2026-04-17 | FORM 8-K | 0001213900-26-046671 | View SEC Doc Filr Page |
| 8-K | 2026-04-16 | 2026-04-15 | CURRENT REPORT | 0001213900-26-044657 | View SEC Doc Filr Page |
| 425 | 2026-04-09 | — | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-26-042030 | View SEC Doc Filr Page |
| 8-K/A | 2026-04-09 | 2026-03-20 | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-26-042017 | View SEC Doc Filr Page |
| NT 10-K | 2026-03-31 | 2025-12-31 | NOTIFICATION OF LATE FILING | 0001213900-26-037575 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-03-30 | — | SCHEDULE 13D/A Filing | 0001213900-26-035996 | View SEC Doc Filr Page |
| 8-K | 2026-03-26 | 2026-03-20 | CURRENT REPORT | 0001213900-26-034786 | View SEC Doc Filr Page |
| 8-K | 2026-03-25 | 2026-03-20 | CURRENT REPORT | 0001213900-26-033832 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-03-20 | — | SCHEDULE 13D/A Filing | 0001213900-26-032480 | View SEC Doc Filr Page |
| 8-K | 2026-03-16 | 2026-03-16 | CURRENT REPORT | 0001213900-26-028332 | View SEC Doc Filr Page |
| DEFM14C | 2026-02-27 | — | INFORMATION STATEMENT | 0001213900-26-020883 | View SEC Doc Filr Page |